Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for XELJANZ
- A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
- Therapies for Down Syndrome Regression Disorder
- Effect of Tofacitinib on Coagulation and Platelet Function, and Its Role in Thromboembolic Events
- COVID-19 VaccinE Response in Rheumatology Patients
- A Study Validating the Use of Candin as a Challenge Agent in Healthy Participants - Intervention Specific Appendix 3
- The Role of Tofacitinib in Steroid Withdrawal in Rheumatoid Arthritis
- Impact of Tapering Immunosuppressants on Maintaining Minimal Disease Activity in Adult Subjects With Psoriatic Arthritis
- Xeljanz and Healthy Diet
- Tofacitinib Citrate Topical Gel 3.2% FDA BA Bridging Study
- Safety and Efficacy of Tofacitinib in Hospitalized Participants With COVID-19 Pneumonia Who Are Receiving Standard of Care Therapy
- TOFAcitinib Plus Hydroxycloroquine vs Hydroxycloroquine in Patients With COVID-19 Interstitial Pneumonia
- Effects of Tofacitinib vs Methotrexate on Rheumatoid Arthritis Interstitial Lung Disease
- Efficiency of Methotrexate and Tofacitinib in Mild and Moderate Patients
- Tofacitinib for Immune Skin Conditions in Down Syndrome
- Study to Evaluate HL-TOF Tab. 5 mg Compared With XelJanz Tab. in Healthy Volunteers
- Tofacitinib for Reduction of Spinal Inflammation in Patients With Psoriatic ArthritiS PresenTing With Axial InvOlvement
- Advanced Therapeutics in Rheumatoid Arthritis (RA)
- Study to Evaluate the Bioequivalence of Pfizer Korea Inc. "XELJANZ 5Mg Tablet" in Healthy Volunteers
- Effectiveness and Safety of Tofacitinib in Patients With Extensive and Recalcitrant Alopecia Areata
- Tofacitinib Hypothesis-generating, Pilot Study for Corticosteroid-Dependent Sarcoidosis
- JAK Inhibition to Prevent Ventilator-induced Diaphragm Dysfunction
- Treatment of Rheumatoid Arthritis With DMARDs: Predictors of Response
- Open-label Study of Tofacitinib for Moderate to Severe Skin Involvement in Young Adults With Lupus
- Evaluation of Tofacitinib in Early Diffuse Cutaneous Systemic Sclerosis (dcSSc)
- A Safety, Efficacy And Pharmacokinetics Study Of Tofacitinib In Pediatric Patients With sJIA
- Safety and Efficacy of Pf-06650833 In Subjects With Rheumatoid Arthritis, With An Inadequate Response To Methotrexate
- Tofacitinib for the Treatment of Alopecia Areata and Its Variants
- Study To Evaluate The Efficacy Of Tofacitinib In Moderate To Severe Alopecia Areata, Totalis And Universalis
- Evaluation of the Condition of Rheumatoid Arthritis After Treatment
- Tofacitinib (Xeljanz) Special Investigation for Rheumatoid Arthritis
Clinical trials list
click for details